Symbols

UTMD

Utah Medical Products·NASDAQ

--(--)

Signals Analysis

Bullish signal 4

Bearish signal 0

Ample Liquidity

High Gross Profit Margin

High Cash/net Profit Ratio

Undervalued

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About UTMD

Utah Medical Products, Inc.

A leading developer and manufacturer of medical devices for obstetrics, gynecology, and neonatal care

Industry

Healthcare Equipment and Supplies

Established Date

Listing Date

03/08/2000

Exchange

NASDAQ Stock Exchange

Full-time Employees

155

Fiscal Year Ends

12-31

Website

www.utahmed.com

Security Type

Common stock

Office address

7043 South 300 West, Midvale, Utah 84047

Business

Introduction

Founded in Utah in 1978, Utah Medical Products, Inc., is engaged in the production of high-quality, cost-effective medical devices, which are mainly self-owned and disposable, mainly used in hospitals. The Company's success depends on (1) recognizing the needs of physicians and customers, (2) rapidly designing or mastering economical solutions to increase premarket regulatory cooperation, (3) producing trusted products to meet clinical needs, and (4) selling products through UTMD's direct channels to markets that need and support resources with a good reputation and considerable sales resources. Or establish relationships with companies that have the resources to effectively support and sell the company's products. Production and sales of professional medical equipment. Its product range includes products for labor and delivery departments in emergency areas and hospitals, as well as outpatient and physician clinics. Its products are sold domestically and internationally.

Company Financials

EPS

UTMD has released its 2024 Q4 earnings. EPS was reported at 0.86, versus the expected 0, beating expectations. The chart below visualizes how UTMD has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

UTMD has released its 2025 Q3 earnings report, with revenue of 9.81M, reflecting a YoY change of -1.93%, and net profit of 2.63M, showing a YoY change of -26.16%. The Sankey diagram below clearly presents UTMD's revenue sources and cost distribution.